MOS testbed for the characterization of targeted alpha therapy pharmaceuticals
MOS testbed for the characterization of targeted alpha therapy pharmaceuticals
DOI | Resolve DOI: https://doi.org/10.1109/JSEN.2014.2365412 |
---|---|
Author | Search for: Griffin, Ryan H1; Search for: Mcconnell, E. M.; Search for: Derosa, M. C.; Search for: Tarr, N. G. |
Name affiliation |
|
Format | Text, Article |
Journal title | IEEE Sensors Journal |
ISSN | 1530-437X 1558-1748 |
Volume | 15 |
Issue | 3 |
Pages | 1690–1696 |
Subject | pharmaceutical development; Metal-Oxide-Semiconductor; MOS; Radioimmunotherapy; RIT; Targeted Alpha Therapy; TAT; Targeted Radionuclide Therapy; TRT; aptamer; DNA; chelator characterization; DOTA |
Abstract | |
Publication date | 2015-03 |
Language | English |
Peer reviewed | Yes |
NPARC number | 23001036 |
Export citation | Export as RIS |
Report a correction | Report a correction | Record identifier | 7445addb-c992-4ef5-9a3a-94762dbba3b9 |
Record created | 2016-12-02 |
Record modified | 2020-04-22 |